Health ❯ Healthcare ❯ Neurology ❯ Stroke

Ischemic Stroke

Bayer Stroke Drug Asundexian Hits Phase III Goals, Shares Jump

The FXIa inhibitor lowered recurrent ischemic risk without more major bleeding in patients on antiplatelet therapy.

Danish Study Finds No Link Between Vaginal Estrogen Tablets and Recurrent Ischemic Stroke